According to WHO study, until now around 70 million people are infected with HIV virus and 35 million died of HIV infection. With rising mortality, the government and non-government institutes are taking initiatives and providing funding for diagnostic treatment and prevention of HIV/AIDS. With advancement of technology, novel diagnostic product are available in market which required minimum technical skills such as portable cell counter and point of care rapid diagnostic tests that fasten the diagnosis process. In developing countries such as India and China with growing population, rising awareness about HIV and emerging economies will be lucrative market for HIV/AIDS diagnostics. Increase in incidence of HIV infection, awareness about HIV/AIDs diagnosis and treatment, rising research and development for early diagnosis, treatment and prevention are key the factors driving the HIV/AIDS diagnostic market.
The report titled “HIV/AIDS Diagnostics Market - Growth, Future Prospects and Competitive Analysis, 2023–2030” offers strategic insights into the overall HIV/AIDS diagnostics market along with the market size and estimates for the duration 2020 to 2029. The said research study covers in-depth analysis of multiple market segments based on type of product and different geographies. The product type segment studied for analyzing the overall global HIV/AIDS diagnostics market is majorly segmented into antibody test, HIV-2 & Group O diagnostic Tests, viral load tests, CD4 testing, early infant diagnostics, viral identification testing.
Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global HIV/AIDS diagnostics market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global HIV/AIDS diagnostics market. This report concludes with company profiles section that highlights major information about the key players engaged in global HIV/AIDS diagnostics market. In-depth competitive environment analysis and historical (2020) market size data are also provided in the report.
HIV/AIDS diagnostics market based on the type of products:
The most widely used test for detection of the HIV infection is antibody testing. Technological advancement in screening tests, rising incidence of HIV and growing awareness about blood donation, act as the major drivers of the antibody testing market. Rapid tests and ELISA form the major markets for the HIV diagnostic tests. With advances in technology, antibody confirmatory have become extremely accurate in giving end result, for example western blot test delivers 100% accuracy result screening post antibody test. Thus owing to high accuracy rate and increase in usage, antibody tests will continue to occupy dominant position in the forecast period. Monitoring tests such as viral load test, and CD4 testing are used to evaluate virologic load and assessment of the treatment safety, are anticipated to be the fastest growing market.
In 2021, North America dominated the global HIV/AIDS diagnostics market followed by the Europe. In North America region, U.S. occupies the maximum share of the market due to rise in prevalence of HIV infection, growing awareness programs and health care access, national funding for HIV affected people. Canada at regional level has different programs laid for treatment of AIDS, which further drives the diagnostic market in the country. Europe is the next important market driven by factors such as convenient access to health care facilities, high healthcare spending and introduction of novel treatment opportunities. Asia Pacific is anticipated to be fastest growing in HIV/AIDS diagnostic market in the forecast period. Developing countries contribute to rising number of HIV-AIDS population, and along with increase in government initiative for HIV diagnostic and treatment facilities, rising healthcare expenditure further drives the diagnostic market for Asia pacific.
Historical & Forecast Period
This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of HIV/AIDS Diagnostics market are as follows:
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
| ATTRIBUTE | DETAILS |
|---|---|
| Research Period | 2022-2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Year | 2022 |
| Unit | USD Million |
| Segmentation | |
Product
| |
|
Region Segment (2022-2032; US$ Million)
|
Key questions answered in this report
